Literature DB >> 17964753

Gallbladder carcinoma.

G Miller1, W R Jarnagin.   

Abstract

Although it is the most common cancer of the biliary tree, gallbladder carcinoma remains an uncommon disease. As a result, many clinicians rarely encounter it and there is uncertainty regarding proper management. Resection is the most effective and only potentially curative treatment. Early stage tumors are often curable with a proper resection; however, many patients present late in the course of the disease when surgical intervention is no longer effective. While other treatment modalities are used in patients with advanced disease, there is limited data on efficacy. In many cases, the diagnosis is made after a cholecystectomy has been performed and an incidental tumor is identified in the specimen. In such cases, reoperation and definitive resection is appropriate and effective for patients with invasive lesions.

Entities:  

Mesh:

Year:  2007        PMID: 17964753     DOI: 10.1016/j.ejso.2007.07.206

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  84 in total

1.  Gallbladder cancer: adenoma-carcinoma or dysplasia-carcinoma sequence?

Authors:  Vivek Trivedi; Vivek V Gumaste; Shaojun Liu; Joel Baum
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-10

2.  Gallbladder cancer: the basics.

Authors:  Eldon A Shaffer
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-10

3.  A Comparative Analysis of Clinical Characteristics and Histomorphologic and Immunohistochemical Spectrum of Gallbladder Carcinoma in Young Adults (< 45 Years) and Elderly Adults (> 60 Years).

Authors:  Suneeta Gupta; Hanni V Gulwani; Sukhpreet Kaur
Journal:  Indian J Surg Oncol       Date:  2020-02-06

4.  The impact of tumor extent (T stage) and lymph node involvement (N stage) on survival after surgical resection for gallbladder adenocarcinoma.

Authors:  Victor Zaydfudim; Irene D Feurer; J Kelly Wright; C Wright Pinson
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

5.  Thyroid metastases from squamous cell carcinoma of gallbladder.

Authors:  Peter C Kurniali; Srinivas Kavuturu; Neil Caliman; Anas Al-Janadi
Journal:  J Gastrointest Cancer       Date:  2014-12

6.  Preoperative C-Reactive Protein/Albumin Ratio as a Predictive Factor for Gallbladder Carcinoma.

Authors:  Masashi Utsumi; Hideki Aoki; Seichi Nagahisa; Seitaro Nishimura; Yuta Une; Yuji Kimura; Megumi Watanabe; Fumitaka Taniguchi; Takashi Arata; Koh Katsuda; Kohji Tanakaya
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

7.  Resection after neoadjuvant chemotherapy in advanced carcinoma of the gallbladder: a retrospective study.

Authors:  Veda Padma Priya Selvakumar; Shuaib Zaidi; Pankaj Pande; Ashish Goel; Kapil Kumar
Journal:  Indian J Surg Oncol       Date:  2015-01-22

8.  Expression of cell cycle-related proteins, p16, p53 and p63 as important prognostic markers in gallbladder adenocarcinoma.

Authors:  Kyungeun Kim; Dong-Hoon Kim; Seoung Wan Chae; Jun-Ho Shin; Hong Joo Kim; Sung-Im Do; Hyun Joo Lee; Ji Hae Koo; Jung-Soo Pyo; Jin Hee Sohn
Journal:  Pathol Oncol Res       Date:  2013-11-01       Impact factor: 3.201

9.  Identification of a candidate stem cell in human gallbladder.

Authors:  Rohan Manohar; Yaming Li; Helene Fohrer; Lynda Guzik; Donna Beer Stolz; Uma R Chandran; William A LaFramboise; Eric Lagasse
Journal:  Stem Cell Res       Date:  2015-02-07       Impact factor: 2.020

10.  Rates and patterns of recurrence after curative intent resection for gallbladder cancer: a multi-institution analysis from the US Extra-hepatic Biliary Malignancy Consortium.

Authors:  Georgios Antonios Margonis; Faiz Gani; Stefan Buettner; Neda Amini; Kazunari Sasaki; Nikolaos Andreatos; Cecilia G Ethun; George Poultsides; Thuy Tran; Kamran Idrees; Chelsea A Isom; Ryan C Fields; Bradley Krasnick; Sharon M Weber; Ahmed Salem; Robert C G Martin; Charles Scoggins; Perry Shen; Harveshp D Mogal; Carl Schmidt; Eliza Beal; Ioannis Hatzaras; Rivfka Shenoy; Shishir K Maithel; Timothy M Pawlik
Journal:  HPB (Oxford)       Date:  2016-08-13       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.